Baird raised the firm’s price target on Cencora (COR) to $292 from $287 and keeps an Outperform rating on the shares. The firm said they delivered another solid report, guided favorably, and announced a very intriguing MSO deal in a new field for distributors; retina care specialists.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter